Nantahala Capital Management - UNICYCIVE THERAPEUTICS INC ownership

UNICYCIVE THERAPEUTICS INC's ticker is and the CUSIP is 90466Y103. A total of 13 filers reported holding UNICYCIVE THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Nantahala Capital Management ownership history of UNICYCIVE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$2,984,666
+260.2%
3,470,541
+436.1%
0.26%
+218.8%
Q2 2023$828,692
-39.0%
647,4160.0%0.08%
-23.1%
Q1 2023$1,359,574
+288.9%
647,4160.0%0.10%
+352.2%
Q4 2022$349,605
-16.6%
647,416
-8.9%
0.02%
-14.8%
Q3 2022$419,000
-30.9%
710,542
-2.6%
0.03%
-10.0%
Q2 2022$606,000
-26.6%
729,680
+13.9%
0.03%
-18.9%
Q1 2022$826,000
-41.6%
640,633
-6.7%
0.04%
-26.0%
Q4 2021$1,415,000
-28.6%
686,756
-1.9%
0.05%
-19.4%
Q3 2021$1,981,000700,0000.06%
Other shareholders
UNICYCIVE THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Ayrton Capital LLC 76,645$45,0000.08%
Nantahala Capital Management 710,542$419,0000.03%
TANDEM CAPITAL MANAGEMENT CORP /ADV 15,500$10,0000.01%
Board of Trustees of The Leland Stanford Junior University 63,019$37,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GEODE CAPITAL MANAGEMENT, LLC 26,109$15,0000.00%
CAPTRUST FINANCIAL ADVISORS 18,800$11,0000.00%
Tower Research Capital LLC (TRC) 5,177$3,0000.00%
FineMark National Bank & Trust 15,625$9,0000.00%
Renaissance Technologies 12,900$8,0000.00%
View complete list of UNICYCIVE THERAPEUTICS INC shareholders